This article is more than 5 years old. Information may no longer be current.
Scientist joins cancer institute
Click Here to Manage Email Alerts
Martin McMahon, PhD, has been appointed professor in the department of dermatology and senior director of pre-clinical translation at Huntsman Cancer Institute at The University of Utah.
McMahon, who will make the transition in August, currently serves as distinguished professor of cancer biology at University of California, San Francisco, and assistant director of professional education and co-leader of the Helen Diller Family Comprehensive Cancer Center Developmental Therapeutics Program.
“Dr. McMahon is a distinguished scientist who is passionate about improving cancer outcomes,” Mary Beckerle, PhD, CEO and director of Huntsman Cancer Institute (HCI), said in a press release. “He is a natural leader who will play a major role in advancing the development of HCI research discoveries to improve cancer treatments.”
Martin McMahon
McMahon — president of the Society for Melanoma Research — will serve as a member of the HCI executive leadership board, the Director’s Cabinet, with key responsibilities in strategic planning and development of the cancer center.
“With the arrival of Dr. McMahon, HCI will be able to take new initiatives in the development of pre-clinical models, so essential to the discovery of not only new treatments for cancer, but prevention strategies as well,” Bradley Cairns, PhD, the cancer institute’s senior director of basic science, said in a press release. “His laboratory will actively pursue the design and evaluation of treatments that will combat a mutant protein, BRAF, known to be at the root of many cancers.”